Media Summary: This webinar will explore the critical steps required to successfully bring Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series.

Commercialization Strategies For Cell And Gene Therapies - Detailed Analysis & Overview

This webinar will explore the critical steps required to successfully bring Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series. Cardinal Health Advanced Therapy Solutions enable breakthroughs in Although there have been improvements in the regulation of Session Chair: Phil Vanek, General Manager,

Being first isn't always easy. Hear from the sector's pioneers as they share valuable lessons learned along the path to ... Moderator: Joshua Schimmer, M.D., Managing Director and Senior Research Analyst, Piper Jaffray Speakers: Faraz Ali, Chief ... Fluor subject matter expert Abhirath S. Parikh, Ph.D. discusses the advances and intricacies of the Join this session to hear experts debate the following industry challenges: - Austere funding and the financial environment ... Christopher Bravery Ph.D., Director of Consulting at Advanced Biologicals Ltd., explains how to overcome the challenges of ...

Photo Gallery

Commercialization Strategies for Cell and Gene Therapies
Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series
Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop
Lessons Learned from Commercial Cell Therapies in the Advancement of IPSC Derived Therapies
Moving Towards Commercialization of a Potentially Curative Gene Therapy
Enabling breakthroughs in cell and gene therapy development & commercialization
Commercialization Learnings with Novartis Gene Therapies' President Chris Fox
Planning for CGT Commercial Readiness: Adaptive Manufacturing Strategy
CMC challenges in cell and gene therapy manufacturing
Plenary Session: Cell Therapy Commercialization Today and Preparing for the Future
Cell Therapy Commercialization in Oncology
Sponsored
Sponsored
View Detailed Profile
Commercialization Strategies for Cell and Gene Therapies

Commercialization Strategies for Cell and Gene Therapies

This webinar will explore the critical steps required to successfully bring

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies

Produced by Pharmaceutical Technology and BioPharm International Presenters: Alan Moore, Chief

Sponsored
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series.

Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop

Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop

READINESS

Lessons Learned from Commercial Cell Therapies in the Advancement of IPSC Derived Therapies

Lessons Learned from Commercial Cell Therapies in the Advancement of IPSC Derived Therapies

Sponsored by FUJIFILM

Sponsored
Moving Towards Commercialization of a Potentially Curative Gene Therapy

Moving Towards Commercialization of a Potentially Curative Gene Therapy

Moving Towards

Enabling breakthroughs in cell and gene therapy development & commercialization

Enabling breakthroughs in cell and gene therapy development & commercialization

Cardinal Health Advanced Therapy Solutions enable breakthroughs in

Commercialization Learnings with Novartis Gene Therapies' President Chris Fox

Commercialization Learnings with Novartis Gene Therapies' President Chris Fox

With 20+

Planning for CGT Commercial Readiness: Adaptive Manufacturing Strategy

Planning for CGT Commercial Readiness: Adaptive Manufacturing Strategy

In the dynamic environment of the

CMC challenges in cell and gene therapy manufacturing

CMC challenges in cell and gene therapy manufacturing

Although there have been improvements in the regulation of

Plenary Session: Cell Therapy Commercialization Today and Preparing for the Future

Plenary Session: Cell Therapy Commercialization Today and Preparing for the Future

Over the past several years, the

Cell Therapy Commercialization in Oncology

Cell Therapy Commercialization in Oncology

Session Chair: Phil Vanek, General Manager,

Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’

Cell & Gene Therapy Trailblazers - Process Development - Chapter 1: ‘DIAGNOSE TO DE-RISK’

To learn more, visit: https://pharma.lonza.com/offerings/

Welcome Remarks and Plenary Session: The Cell and Gene Therapy Sector's Commercial Trailblazers

Welcome Remarks and Plenary Session: The Cell and Gene Therapy Sector's Commercial Trailblazers

Being first isn't always easy. Hear from the sector's pioneers as they share valuable lessons learned along the path to ...

Planning for Cell & Gene Therapy Commercialization

Planning for Cell & Gene Therapy Commercialization

Planning for

Panel: Gene Therapy: Commercialization Readiness and Market Access Challenges

Panel: Gene Therapy: Commercialization Readiness and Market Access Challenges

Moderator: Joshua Schimmer, M.D., Managing Director and Senior Research Analyst, Piper Jaffray Speakers: Faraz Ali, Chief ...

Site Design Considerations for Cell and Gene Therapy Commercial Facilities

Site Design Considerations for Cell and Gene Therapy Commercial Facilities

Fluor subject matter expert Abhirath S. Parikh, Ph.D. discusses the advances and intricacies of the

Addressing the Production Needs of Cell and Gene Therapeutics: New Strategies for a Changing World

Addressing the Production Needs of Cell and Gene Therapeutics: New Strategies for a Changing World

Join this session to hear experts debate the following industry challenges: - Austere funding and the financial environment ...

Three challenges to commercializing cell therapy

Three challenges to commercializing cell therapy

Christopher Bravery Ph.D., Director of Consulting at Advanced Biologicals Ltd., explains how to overcome the challenges of ...

Cell Therapy Commercialization in Oncology

Cell Therapy Commercialization in Oncology

Session Chair: Phil Vanek, General Manager,